Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$693M |
| 2 |
Constellation Brands
STZ
|
+$368M |
| 3 |
Tesla
TSLA
|
+$332M |
| 4 |
NVIDIA
NVDA
|
+$300M |
| 5 |
Booking.com
BKNG
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$821M |
| 2 |
Netflix
NFLX
|
+$777M |
| 3 |
AbbVie
ABBV
|
+$583M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$477M |
| 5 |
FedEx
FDX
|
+$456M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.07% |
| 2 | Consumer Discretionary | 17.72% |
| 3 | Financials | 13.25% |
| 4 | Healthcare | 11.94% |
| 5 | Communication Services | 11.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Columbia Banking Systems
COLB
$8.74B
| $2.09M | ﹤0.01% |
50,996
-5,798
| -10% | -$248K |
|
527
FTI Consulting
FCN
$4.88B
| $2.06M | ﹤0.01% |
+33,974
| New | +$1.97M |
|
528
Glacier Bancorp
GBCI
$6.38B
| $2M | ﹤0.01% |
51,781
+5,792
| +13% | +$226K |
|
529
Booz Allen Hamilton
BAH
$8.59B
| $1.97M | ﹤0.01% |
+45,102
| New | +$1.89M |
|
530
Chemed
CHE
$6.76B
| $1.95M | ﹤0.01% |
+6,057
| New | +$1.9M |
|
531
Grand Canyon Education
LOPE
$3.84B
| $1.95M | ﹤0.01% |
+17,424
| New | +$1.91M |
|
532
AMC Global Media
AMCX
$445M
| $1.9M | ﹤0.01% |
+30,610
| New | +$1.75M |
|
533
Mueller Water Products
MWA
$3.94B
| $1.88M | ﹤0.01% |
160,258
+124,295
| +346% | +$1.39M |
|
534
Lear
LEA
$7.26B
| $1.87M | ﹤0.01% |
10,086
-894
| -8% | -$175K |
|
535
Herbalife
HLF
$1.26B
| $1.87M | ﹤0.01% |
+34,811
| New | +$1.83M |
|
536
Virtu Financial
VIRT
$5.12B
| $1.87M | ﹤0.01% |
+70,401
| New | +$2.27M |
|
537
RBC Bearings
RBC
$18.5B
| $1.87M | ﹤0.01% |
14,499
-517
| -3% | -$64.2K |
|
538
Trip.com Group
TCOM
$28.2B
| $1.82M | ﹤0.01% |
38,201
+225
| +0.6% | +$10.2K |
|
539
Ciena
CIEN
$53.4B
| $1.75M | ﹤0.01% |
66,042
+45,450
| +221% | +$1.15M |
|
540
Nu Skin
NUS
$250M
| $1.71M | ﹤0.01% |
21,862
-3,679
| -14% | -$285K |
|
541
Provident Financial Services
PFS
$3.11B
| $1.66M | ﹤0.01% |
60,246
-18,450
| -23% | -$501K |
|
|
RNTX
542
Rein Therapeutics
RNTX
$66.9M
| $1.63M | ﹤0.01% |
15,065
+190
| +1% | +$21.5K |
|
543
Westlake Corp
WLK
$9.27B
| $1.63M | ﹤0.01% |
15,159
-26,234
| -63% | -$2.94M |
|
544
Silicon Laboratories
SLAB
$7.17B
| $1.55M | ﹤0.01% |
15,529
-5,784
| -27% | -$578K |
|
545
Brinker International
EAT
$8.38B
| $1.5M | ﹤0.01% |
+31,519
| New | +$1.4M |
|
546
Baidu
BIDU
$35.8B
| $1.49M | ﹤0.01% |
6,132
+35
| +0.6% | +$8.71K |
|
547
Group 1 Automotive
GPI
$4.01B
| $1.47M | ﹤0.01% |
23,306
-834
| -3% | -$56.8K |
|
548
Marcus & Millichap
MMI
$1.18B
| $1.45M | ﹤0.01% |
37,165
-1,324
| -3% | -$48.8K |
|
549
United Natural Foods
UNFI
$2.97B
| $1.36M | ﹤0.01% |
31,937
+14,293
| +81% | +$631K |
|
550
Asbury Automotive
ABG
$4.22B
| $1.35M | ﹤0.01% |
19,721
-724
| -4% | -$50.7K |
|
Similar funds
Jennison Associates's Q2 2018 Portfolio in Review
As of Q2 2018, Jennison Associates held 740 positions worth $103B, up 2% from $101B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Jennison Associates withdrew a net $3.95B in Q2 2018, closing 87 positions and reducing 296 holdings. Its most notable exit was Great Plains Energy Incorporated, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jennison Associates opened a new position in AstraZeneca worth $677M.
- Jennison Associates's largest Q2 2018 buy was AstraZeneca: 9,637,084 shares worth $677M.
- Jennison Associates added most to Constellation Brands in Q2 2018, an estimated $368M increase.
- Jennison Associates's biggest Q2 2018 reduction was Charter Communications, cutting an estimated $821M.
- Jennison Associates fully exited Great Plains Energy Incorporated in Q2 2018, selling an estimated $152M.
- Jennison Associates's ten largest holdings make up 29% of its $103B portfolio in Q2 2018.
- Jennison Associates opened 89 new positions and closed 87 in Q2 2018.
- Jennison Associates's portfolio value rose 2% quarter-over-quarter to $103B.
Based on Jennison Associates's 13F filing for Q2 2018, filed 2 Aug 2018.